Clinical trial
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After Laparoscopic Splenectomy and Azygoportal Disconnection
NCT07461532 is registered in ClinicalTrials.gov with Northern Jiangsu People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After Laparoscopic Splenectomy and Azygoportal Disconnection
- Lead sponsor
- Northern Jiangsu People's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2026
- Completion date
- September 30, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis, hypertension, portal, portal vein thrombosis, splenectomy